Newsfiscal.ai
Fractyl Health Announces Strategic Reprioritization and Workforce Reduction
· Published
Article summary
Fractyl Health is sharpening its focus on its lead product candidate, Revita, while discontinuing its Rejuva gene therapy program and reducing its workforce by approximately 45%.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…